Letrozole decreases estrogen levels at 12 months but not 24 months, reduces bone density, does not reduce mammographic breast density at 12 months and increases IGF-1 (a known carcinogen) at 12 and 24 months in | GreenMedInfo | Toxic Article | Natural Med
Links shared publicly online about this topic.
- 580total visits
Letrozole decreases estrogen levels at 12 months but not 24 months, reduces bone density, does not reduce mammographic breast density at 12 months and increases IGF-1 (a known carcinogen) at 12 and 24 months in | GreenMedInfo | Toxic Article | Natural Med
This toxicological article on GreenMedInfo.com concerns - A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women.
View full resource at greenmedinfo.com
Tags: Poison, Breast Cancer Medication, Bone, Women's Health, Femara, Estrogen
Most Recently Shared on January 14, 2011 at 11:36 pm By:
It is disgusting to me that Aromatase Inhibitors like Femara (letrozole) which are given to women to prevent... http://fb.me/sU1rb4cI
Advertisement
